Skip to main content
Search
Search
Advanced Search
Skip main navigation
Free access
Research Article
21 October 2021

Cost–utility analysis of single nucleotide polymorphism panel-based machine learning algorithm to predict risk of opioid use disorder

Authors: Peter J Mallow https://orcid.org/0000-0001-9642-2977 [email protected] and Kathy W BelkAuthor Info & Affiliations
Volume 10, Number 18
https://doi.org/10.2217/cer-2021-0115
PDFFormats

Abstract

Aim: To conduct a cost–utility analysis of a novel genetic diagnostic test (OUDTEST) for risk of developing opioid use disorder for elective orthopedic surgery patients. Materials & Methods: A simulation model assessed cost–effectiveness and quality-adjusted life-years (QALYs) for OUDTEST from private insurer and self-insured employer perspectives over a 5-year time horizon for a hypothetical patient population. Results: OUDTEST was found to cost less and increase QALYs, over a 5-year period for private insurance (savings US$2510; QALYs 0.02) and self-insured employers (-US$2682; QALYs 0.02). OUDTEST was a dominant strategy in 71.1% (private insurance) and 72.7% (self-insured employer) of model iterations. Sensitivity analyses revealed robust results except for physician compliance. Conclusion: OUDTEST was expected to be a cost-effective solution for personalizing postsurgical pain management in orthopedic patients.

Supplementary Material

File (appendix a.docx)

References

Papers of special note have been highlighted as: • of interest; •• of considerable interest
1.
Schieber LS, Guy GP, Seth P. Trends and patterns of geographic variation in opioid prescribing practices by state, United States, 2006–2017. JAMA Netw. Open 2(3), e190665 (2019).
PubMed
Google Scholar
2.
Guy GP Jr, Zhang K, Bohm MK et al. Vital signs: changes in opioid prescribing in the United States, 2006–2015. MMWR Morb. Mortal. Wkly. Rep. 66(26), 697–704 (2017).
PubMed
Google Scholar
3.
CDC, Drug Overdose. Prescription opioid overdose death maps. https://www.cdc.gov/drugoverdose/deaths/prescription/maps.html
Google Scholar
4.
CDC, National Center for Health Statistics. 2020. Wide-ranging online data for epidemiologic research (WONDER). http://wonder.cdc.gov
Google Scholar
5.
Brummett CM, Evans-Shields J, England C et al. Increased health care costs associated with new persistent opioid use after major surgery in opioid-naive patients. J. Manag. Care Spec. Pharm. 1–12 (2021).
Crossref
Google Scholar
6.
Florence CS, Zhou C, Luo F, Xu L. The economic burden of prescription opioid overdose, abuse, and dependence in the United States, 2013. Med. Care 54(10), 901–906 (2016).
PubMed
Google Scholar
7.
Hah JM, Bateman BT, Ratliff J, Curtin C, Sun E. Chronic opioid use after surgery: implications for perioperative management in the face of the opioid epidemic. Anesth. Analg. 125(5), 1733–1740 (2017).
PubMed
Google Scholar
8.
Wyles CC, Hevesi M, Trousdale ER et al. The 2018 Chitranjan S. Ranawat, MD Award: developing and implementing a novel institutional guideline strategy reduced postoperative opioid prescribing after TKA and THA. Clin. Orthop. Relat. Res. 477(1), 104–113 (2019).
PubMed
Google Scholar
9.
Rudd RA, Seth P, David F, Scholl L. Increases in drug and opioid-involved overdose deaths - United States, 2010–2015. MMWR Morb. Mortal. Wkly. Rep. 65(50–51), 1445–1452 (2016).
PubMed
Google Scholar
10.
Larochelle MR, Liebschutz JM, Zhang F, Ross-Degnan D, Wharam JF. Opioid prescribing after nonfatal overdose and association with repeated overdose. Ann. Intern. Med. 165(5), 376–377 (2016).
PubMed
Google Scholar
11.
Wunsch H, Wijeysundera DN, Passarella MA, Neuman MD. Opioids prescribed after low-risk surgical procedures in the United States, 2004–2012. JAMA 315(15), 1654–1657 (2016).
PubMed
Google Scholar
12.
Calcaterra SL, Yamashita TE, Min SJ, Keniston A, Frank JW, Binswanger IA. Opioid prescribing at hospital discharge contributes to chronic opioid use. J. Gen. Intern. Med. 31(5), 478–485 (2016).
PubMed
Google Scholar
13.
Alam A, Gomes T, Zheng H, Mamdani MM, Juurlink DN, Bell CM. Long-term analgesic use after low-risk surgery: a retrospective cohort study. Arch. Intern. Med. 172(5), 425–430 (2012).
PubMed
Google Scholar
14.
Sun EC, Darnall BD, Baker LC, Mackey S. Incidence of and risk factors for chronic opioid use among opioid-naive patients in the postoperative period. JAMA Intern. Med. 176(9), 1286–1293 (2016).
PubMed
Google Scholar
15.
Quinlan J, Rann S, Bastable R, Levy N. Perioperative opioid use and misuse. Clin. Med. (Lond.) 19(6), 441–445 (2019).
PubMed
Google Scholar
16.
Coluzzi F, Bifulco F, Cuomo A et al. The challenge of perioperative pain management in opioid-tolerant patients. Ther. Clin. Risk Manag. 13, 1163–1173 (2017).
PubMed
Google Scholar
17.
Gulur P, Nelli AH. The Opioid-tolerant patient: opioid optimization. J. Arthroplasty 35(6S), S50–S52 (2020).
PubMed
Google Scholar
18.
Sceats LA, Ayakta N, Merrell SB, Kin C. Drivers, Beliefs, and Barriers Surrounding surgical opioid prescribing: a qualitative study of surgeons' opioid prescribing habits. J. Surg. Res. 247, 86–94 (2020).
PubMed
Google Scholar
19.
Sabatino MJ, Kunkel ST, Ramkumar DB, Keeney BJ, Jevsevar DS. Excess opioid medication and variation in prescribing patterns following common orthopaedic procedures. J. Bone Joint Surg. Am. 100(3), 180–188 (2018).
PubMed
Google Scholar
20.
Chen JH, Humphreys K, Shah NH, Lembke A. Distribution of opioids by different types of medicare prescribers. JAMA Intern. Med. 176(2), 259–261 (2016).
PubMed
Google Scholar
21.
Morris BJ, Mir HR. The opioid epidemic: impact on orthopaedic surgery. J. Am. Acad. Orthop. Surg. 23(5), 267–271 (2015).
PubMed
Google Scholar
22.
Soffin EM, Waldman SA, Stack RJ, Liguori GA. An evidence-based approach to the prescription opioid epidemic in orthopedic surgery. Anesth. Analg. 125(5), 1704–1713 (2017).
PubMed
Google Scholar
23.
Inacio MC, Hansen C, Pratt NL, Graves SE, Roughead EE. Risk factors for persistent and new chronic opioid use in patients undergoing total hip arthroplasty: a retrospective cohort study. BMJ Open 6(4), e010664 (2016).
PubMed
Google Scholar
24.
Zarling BJ, Yokhana SS, Herzog DT, Markel DC. Preoperative and postoperative opiate use by the arthroplasty patient. J. Arthroplasty 31(10), 2081–2084 (2016).
PubMed
Google Scholar
25.
Soffin EM, Lee BH, Kumar KK, Wu CL. The prescription opioid crisis: role of the anaesthesiologist in reducing opioid use and misuse. Br. J. Anaesth. 122(6), e198–e208 (2019).
PubMed
Google Scholar
26.
Bicket MC, Brat GA, Hutfless S, Wu CL, Nesbit SA, Alexander GC. Optimizing opioid prescribing and pain treatment for surgery: review and conceptual framework. Am. J. Health Syst. Pharm. 76(18), 1403–1412 (2019).
PubMed
Google Scholar
27.
Johnson RL, Amundson AW, Abdel MP et al. Continuous posterior lumbar plexus nerve block versus periarticular injection with Ropivacaine or Liposomal Bupivacaine for total hip arthroplasty: a three-arm randomized clinical trial. J. Bone Joint Surg. Am. 99(21), 1836–1845 (2017).
PubMed
Google Scholar
28.
Thiels CA, Anderson SS, Ubl DS et al. Wide variation and over prescription of opioids after elective surgery. Ann. Surg. 266(4), 564–573 (2017).
PubMed
Google Scholar
29.
Blanco C, Volkow ND. Management of opioid use disorder in the USA: present status and future directions. Lancet 393(10182), 1760–1772 (2019).
PubMed
Google Scholar
30.
Klimas J, Gorfinkel L, Fairbairn N et al. Strategies to identify patient risks of prescription opioid addiction when initiating opioids for pain: a systematic review. JAMA Netw. Open 2(5), e193365 (2019).
PubMed
Google Scholar
31.
Crist RC, Reiner BC, Berrettini WH. A review of opioid addiction genetics. Curr. Opin. Psychol. 27, 31–35 (2019).
PubMed
Google Scholar
32.
Berrettini W. A brief review of the genetics and pharmacogenetics of opioid use disorders. Dialogues Clin. Neurosci. 19(3), 229–236 (2017).
PubMed
Google Scholar
33.
Kringel D, Ultsch A, Zimmermann M et al. Emergent biomarker derived from next-generation sequencing to identify pain patients requiring uncommonly high opioid doses. Pharmacogenomics J. 17(5), 419–426 (2017).
PubMed
Google Scholar
34.
Wang SC, Chen YC, Lee CH, Cheng CM. Opioid addiction, genetic susceptibility, and medical treatments: a review. Int. J. Mol. Sci. 20(17), 4294 (2019).
PubMed
Google Scholar
35.
Elmallah RK, Ramkumar PN, Khlopas A et al. Postoperative pain and analgesia: is there a genetic basis to the opioid crisis? Surg. Technol. Int. 32, 306–314 (2018).
PubMed
Google Scholar
36.
Donaldson K, Demers L, Taylor K, Lopez J, Chang S. Multi-variant genetic panel for genetic risk of opioid addiction. Ann. Clin. Lab. Sci. 47(4), 452–456 (2017).
PubMed
Google Scholar
•• Demonstrates the viability of a genetic diagnostic test for identifying individuals who may be at an increased risk of developing opioid use disorder.
37.
Donaldson K, Cardamone D, Genovese M, Garbely J, Demers L. Clinical performance of a gene-based machine learning classifier in assessing risk of developing OUD in subjects taking oral opioids: a prospective observational study. Ann. Clin. Lab. Sci. 51(4), 451–460 (2021).
PubMed
Google Scholar
•• This was the clinical study that validated the use of a genetic test for accurately screening for the risk of opioid use disorder (OUD). The results of this analysis are based on this test.
38.
Politzer CS, Kildow BJ, Goltz DE, Green CL, Bolognesi MP, Seyler TM. Trends in opioid utilization before and after total knee arthroplasty. J. Arthroplasty 33(7S), S147–S153 e141 (2018).
PubMed
Google Scholar
• Highlights the substantial risk of developing OUD postorthopedic procedure.
39.
Kim KY, Anoushiravani AA, Chen KK, Roof M, Long WJ, Schwarzkopf R. Preoperative chronic opioid users in total knee arthroplasty-which patients persistently abuse opiates following surgery? J. Arthroplasty 33(1), 107–112 (2018).
PubMed
Google Scholar
• Highlights the substantial risk of developing OUD postorthopedic procedure.
40.
US Bureau of Labor Statistics (BLS). Labor Force Statistics from the Current Population Survey, 2019. https://www.bls.gov
Google Scholar
41.
White AG, Spittle T, Fernan C, Billmyer E, Marrett E, Kwong WJ et al. Assessment of work loss associated with prescription-related opioid use disorder. JOEM 62(2), 217–222 (2020).
Google Scholar
42.
Krebs E, Min JE, Evans E, Li L, Liu L, Huang D et al. Estimating state transitions for opioid use disorders. Med. Decis. Making 37, 483–497 (2017).
PubMed
Google Scholar
43.
Evans E, Li L, Min J, Huang D, Urada D, Liu L et al. Mortality among individuals accessing pharmacological treatment for opioid dependence in California, 2006–10. Addiction 110, 996–1005 (2015).
PubMed
Google Scholar
44.
Social Security Administration. Actuarial Life Table. 2016. https://www.ssa.gov/oact/STATS/table4c6.html
Google Scholar
45.
Institute for Clinical and Economic Review (ICER). Abuse-deterrent formulations of opioids: effectiveness and value. https://www.icer.org
Google Scholar
46.
Frank JW, Carey E, Nolan C et al. Increased nonopioid chronic pain treatment in the veterans' health administration, 2010–2016. Pain Med. 20(5), 869–877 (2019).
PubMed
Google Scholar
47.
Scarpati LM, Kirson NY, Jia ZB, Wen J, Howard J. Opioid abuse: a detailed examination of cost drivers over 24-Month follow-up period. J. Manag. Care Spec. Pharm. 23(11), 1110–1115 (2017).
PubMed
Google Scholar
48.
Jalali A, Ryan DA, Jeng PJ, McCollister KE, Leff JA, Lee JD et al. Health-related quality of life and opioid use disorder pharacotherapy: a secondary analysis of a clinical trial. Drug Alchol. Depend. 1(215), 108221 (2020).
Google Scholar
49.
Jones CM, Paulozzi LJ, Mack KA. Sources of prescription opioid pain relievers by frequency of past-year nonmedical use United States, 2008–2011. JAMA Intern. Med. 174(5), 802–803 (2014).
PubMed
Google Scholar
50.
Webster LR, Webster RM. Predicting aberrant behaviors in opioid-treated patients: preliminary validation of the opioid risk tool. Pain Med. 6(6), 432–442 (2005).
PubMed
Google Scholar
51.
Phiri D, Mallow PJ, Rizzo JA. The cost-effectiveness of hand-held ultrasound screening for abdominal aortic aneurysm in older males with a history of smoking. JHEOR 1(2), 96–107 (2013).
Google Scholar
|